“…The RP is based on the critical health effect and is, whenever possible, recommended to be derived by the benchmark dose (BMD) approach (Crump, 1984;Dourson et al, 1985;EFSA, 2005EFSA, , 2009EFSA, , 2017Haber et al, 2018;US EPA, 2005, 2012. Sand et al (2018) proposed to expand the current approach by characterizing the dose-related sequence of RPs (e.g., BMDs) associated with lower-to higher-order health effects, representing low to high severities, instead of only using a single RP, for the critical health effect, as a basis for risk characterization. Modeling of data describing different severities has previously been performed by regression methods designed to handle categories (discrete data).…”